Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded: FDA Warning Letter to giantnic.com, 2026-08-07
Letter issued · posted to fda.gov .
Subject as published: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
TL;DR
At a glance: **FDA Warning Letter to giantnic.com (Reference RW2602438, August 7, 2026)** The FDA Center for Tobacco Products determined that giantnic.com sold an Oxbar Astro Maze 50K Disposable Snickerdiddler electronic nicotine delivery system (ENDS) product to a person under 21 years of age during an FDA investigation, violating section 906(d)(5) of the FD&C Act and rendering the product misbranded under section 903(a)(7)(B). The FDA requests written response within 15 working days detailing corrective actions, compliance plans, and discontinuation of violative sales, warning that failure to comply may result in civil penalties, seizure, and injunction.
Argus analysis
# FDA Warning Letter Analysis: giantnic.com
**Company and Violations**
Giantnic.com, an online retailer operating from Dallas, Texas, received a warning letter from the FDA's Center for Tobacco Products on August 7, 2026. The agency determined that the company sold electronic nicotine delivery system (ENDS) products—specifically an Oxbar Astro Maze 50K Disposable product—to a consumer under 21 years of age. During FDA's undercover investigation of the website, an underage purchaser successfully completed a transaction, establishing a direct violation of federal tobacco sales restrictions.
**Regulatory Citations and Requirements**
The violation centers on section 906(d)(5) of the Federal Food, Drug, and Cosmetic Act, which prohibits any retailer from selling tobacco products to anyone under 21. Under section 903(a)(7)(B), products sold in violation of this age restriction are considered misbranded. The company must also comply with 21 CFR Parts 1140, 1141, and 1143, which establish comprehensive labeling, advertising, and sales compliance standards for tobacco products. These regulations require age-verification systems and restrictions on marketing channels that might appeal to minors.
**Response Timeline and Industry Monitoring**
The company has 15 working days from receipt to submit a written response describing corrective actions and compliance plans. Compliance officers in the e-commerce tobacco sector should monitor whether giantnic.com implements age-verification technology, removes violative products, and addresses similar violations across all sales channels. The FDA copied hosting and payment-processing platforms, signaling potential downstream enforcement. Peers should expect continued undercover purchasing enforcement and potential civil penalties, seizure, or injunction if violations persist.
Severity context
Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
Regulatory background
Tobacco letters cite the Family Smoking Prevention and Tobacco Control Act, primarily Section 910 (premarket review of new tobacco products) for ENDS / e-vapor SKUs.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER giantnic.com MARCS-CMS 735905 — August 07, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Reference #: RW2602438 Product: Tobacco Recipient: giantnic.com 11528 Harry Hines Boulevard Suite B-213 Dallas , TX 75229 United States sales@giantnic.com giantnic@gmail.com support@giantnic.com Issuing Office: Center for Tobacco Products United States August 7, 2026 WARNING LETTER To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://giantnic.com and determined that electronic nicotine delivery system (ENDS) products listed there are offered for sale or distribution to consumers in the United States. Under section 201(rr) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. § 321(rr)), these products are tobacco products because they are made or derived from tobacco or contain nicotine from any source, and are intended for human consumption. 1 Certain tobacco products, including ENDS products, are subject to FDA jurisdiction under section 901 of the FD&C Act (21 U.S.C. § 387a) and 21 C.F.R. § 1100.1, and are required to be in compliance with the requirements in the FD&C Act. Under section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)), it is unlawful for any retailer 2 to sell a tobacco product to any person younger than 21 years of age. 3 This includes tobacco products containing nicotine from any source including cigarettes, smokeless tobacco, cigars, e-cigarettes, and nicotine pouches. Tobacco Product Sold by a Retailer to an Individual Under the Age of 21 is Misbranded Under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)), tobacco products are misbranded if sold or distributed by any retailer to a person younger than 21 years of age in violation of section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)). FDA has determined that your Oxbar Astro Maze 50K Disposable Snickerdiddler ENDS product is misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)) because this product was sold to a person younger than 21 years of age. Specifically, during FDA’s investigation of https://giantnic.com, a person younger than 21 years of age purchased Oxbar Astro Maze 50K Disposable Snickerdiddler ENDS product from your website. Conclusion and Requested Actions It is your responsibility to ensure that your tobacco products and all related labeling and/or advertising on this website, on any other websites (including e-commerce, social networking, or search engine websites), in any other media in which you advertise, and in any retail establishments comply with each applicable provision of the FD&C Act and FDA’s implementing regulations. Failure to address any violations of the FD&C Act, 21 U.S.C. § 301 et seq., and FDA’s implementing regulations, including those in 21 C.F.R. Parts 1140, 1141, and 1143, may lead to regulatory action, incl…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has giantnic.com had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for giantnic.com as of 2026-08-18. Argus ingests new FDA enforcement records daily.
- What FDA violations was giantnic.com cited for?
- The FDA Warning Letter to giantnic.com (issuing office: Center for Tobacco Products) cites: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Classification: Tobacco / ENDS.
- When did FDA issue the warning letter to giantnic.com?
- FDA issued the letter (MARCS-CMS 735905) on 2026-08-07 and posted it publicly on fda.gov on 2026-08-18.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded: FDA Warning Letter to giantnic.com, 2026-08-07. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-giantnic-com-2026-08-07-tobacco
"Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded: FDA Warning Letter to giantnic.com, 2026-08-07." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-giantnic-com-2026-08-07-tobacco.
Argus HQ Research. "Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded: FDA Warning Letter to giantnic.com, 2026-08-07." Digital Empire Holdings LLC. Accessed August 19, 2026. https://argushq.ai/fda/warning-letter/fda-wl-giantnic-com-2026-08-07-tobacco.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_giantnic_com_2026_08_07_tobacco_2026,
title = {Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded: FDA Warning Letter to giantnic.com, 2026-08-07},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-giantnic-com-2026-08-07-tobacco},
note = {Accessed: August 19, 2026}
}